Balance of Fatty Acids and Their Correlations with Parameters of Lipid Metabolism and Markers of Inflammation in Men with Coronary Atherosclerosis
- Авторлар: Polonskaya Y.1, Shramko V.1, Morozov S.2, Chernyak E.2, Chernyavsky A.3, Ragino Y.1
-
Мекемелер:
- Research Institute of Therapy and Preventive Medicine
- N. N. Vorozhtsov Novosibirsk State University of Organic Chemistry
- E.N. Meshalkin Siberian Federal Biomedical Research Center, Ministry of Health of the Russian Federation
- Шығарылым: Том 164, № 1 (2017)
- Беттер: 33-35
- Бөлім: Article
- URL: https://journals.rcsi.science/0007-4888/article/view/239341
- DOI: https://doi.org/10.1007/s10517-017-3920-x
- ID: 239341
Дәйексөз келтіру
Аннотация
We studied the balance of fatty acids and their correlation with parameters of lipid metabolism and inflammation markers in men with coronary atherosclerosis. In the blood of patients and healthy men, the content of myristic (C14:0), pentadecanoic (C15:0), palmitic (C16:0), stearic (C18:0), arachidic (C20:0) and docosanic (C22:0), TNFα, IL-1β, IL-6, IL-8, C-reactive protein, cholesterol, triglycerides, HDL, and LPO intensity were measured. In patients with coronary atherosclerosis, increased concentrations of saturated fatty acids, triglycerides, LPO products, IL-6, IL-8, and C-reactive protein were found. Correlation analysis revealed multiple correlations between the studied fatty acids, correlation of C16:0, C18:0, and C20:0 with inflammation markers, C14:0, C16:0, and C18:0 with triglyceride level, C16:0, C18:0, and C20:0 with cholesterol. The contents of C14:0, C15:0, C16:0, and C18:0 correlated with the presence of coronary atherosclerosis. Lipid metabolism disturbances in coronary atherosclerosis were accompanied by changes in not only lipid spectrum and inflammation markers, but also fatty acids balance.
Авторлар туралы
Ya. Polonskaya
Research Institute of Therapy and Preventive Medicine
Хат алмасуға жауапты Автор.
Email: yana-polonskaya@yandex.ru
Ресей, Novosibirsk
V. Shramko
Research Institute of Therapy and Preventive Medicine
Email: yana-polonskaya@yandex.ru
Ресей, Novosibirsk
S. Morozov
N. N. Vorozhtsov Novosibirsk State University of Organic Chemistry
Email: yana-polonskaya@yandex.ru
Ресей, Novosibirsk
E. Chernyak
N. N. Vorozhtsov Novosibirsk State University of Organic Chemistry
Email: yana-polonskaya@yandex.ru
Ресей, Novosibirsk
A. Chernyavsky
E.N. Meshalkin Siberian Federal Biomedical Research Center, Ministry of Health of the Russian Federation
Email: yana-polonskaya@yandex.ru
Ресей, Novosibirsk
Y. Ragino
Research Institute of Therapy and Preventive Medicine
Email: yana-polonskaya@yandex.ru
Ресей, Novosibirsk